Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
15 drugs in development
By Therapeutic Area
top 5
R&D Momentum
81/100
Pipeline Velocity
50/100
Trial Completion Rate
80/100
Pipeline Concentration
33/100
Pipeline Freshness
42/100
Strategic Signals
Activity
Last 14 days
EAT-UP - Extended Antibiotic Treatment in Chronic UTI Patients; a Phase II Safety and Efficacy Trial
PD Frontline, Part of RAPSODI GD (Remote Assessment of Parkinsonism Supporting Ongoing Development of Interventions in Gaucher's Disease) to Build an Online Trial-ready Cohort of GBA Genotyped People With Parkinson's
Monitoring and Early Detection of Treatable Inherited RETinal Disease in Children and Adolescents
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding
BARI-STEP:A Double-blinded, Randomised, Placebo-controlled Trial of Semaglutide 2.4 mg in Patients With Poor Weight-loss Following Bariatric Surgery.
Accuracy, Efficiency and Acceptability of AI-driven Pure-tone Audiometry (AI-PTA) Compared With Manual Pure-tone Audiometry in Adults With Sensorineural Hearing Loss With and Without Concurrent Tinnitus: the AI-enhanced HEaring Assessment and Delivery (AHEAD) Study
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)